Beraprost Sodium Tablet improves intermittent claudication, pain, ulceration, coldness and other symptoms triggered by arterial occlusion, with significant therapeutic effects. By inhibiting the prostacyclin receptor in the body, Beprostone Sodium Tablet inhibits platelet aggregation and adhesion, and plays the role of antiplatelet, as well as dilates blood vessels and increases blood flow. The use of the drug can lead to patients with flushing, nausea and diarrhea, headache, rash, itching, loss of appetite, nosebleed, etc. Serious adverse reactions are to increase the bleeding tendency of the patient, triggering gastrointestinal hemorrhage, pulmonary hemorrhage, etc., and can also lead to shock, interstitial pneumonitis, angina pectoris, myocardial infarction, hepatic function abnormalities and so on. Note that patients with bleeding tendency, pregnancy and patients who may be pregnant are prohibited. Patients need to be treated under the guidance of professional physicians, do not use drugs without authorization.